Mani Foroohar
Stock Analyst at Leerink Partners
(1.45)
# 1675
Out of 5,368 analysts
213
Total ratings
44.94%
Success rate
11.42%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
RCKT Rocket Pharmaceutica... | Downgrades: Market Perform | 37 8 | 2.94 | 172.11% | 11 | May 28, 2025 | |
LXEO Lexeo Therapeutics | Maintains: Outperform | 19 18 | 3.94 | 356.85% | 3 | Mar 24, 2025 | |
RXRX Recursion Pharmaceut... | Maintains: Market Perform | 7 6 | 4.92 | 21.95% | 8 | Feb 28, 2025 | |
FDMT 4D Molecular Therape... | Maintains: Outperform | 31 27 | 4.39 | 515.03% | 9 | Jan 13, 2025 | |
NGNE Neurogene | Maintains: Outperform | 45 72 | 19.77 | 264.19% | 2 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 17 | 1.55 | 996.77% | 1 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 47 49 | 49.6 | -1.21% | 11 | Oct 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 47 46 | 39.74 | 15.75% | 15 | Oct 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 20 22 | 6.96 | 216.09% | 6 | Oct 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 53 62 | 35.58 | 74.26% | 15 | Jul 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 13 | 16.4 | -20.73% | 1 | Jul 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 29 | 21.43 | 35.32% | 1 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 165 230 | 36.17 | 535.89% | 1 | Jun 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 12 4 | 5.58 | -28.32% | 2 | Apr 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | n/a | n/a | n/a | 10 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 31 | 3.32 | 833.73% | 1 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 23 | n/a | n/a | 10 | Dec 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 7 | 0.59 | 1086.44% | 1 | Nov 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 40 | 15.73 | 154.29% | 12 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 7 2 | n/a | n/a | 5 | Mar 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 111 93 | 26.68 | 248.58% | 17 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 86 84 | 8.31 | 910.83% | 4 | Jan 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 6 7 | 1.97 | 255.33% | 4 | Jan 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 180 160 | n/a | n/a | 10 | Jan 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 81 77 | 17.07 | 351.08% | 2 | Jan 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 144 143 | 307.82 | -53.54% | 11 | Jan 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 19 15 | n/a | n/a | 6 | Jan 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 77 14 | n/a | n/a | 4 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 5 6 | 6.16 | -2.6% | 5 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 75 76 | 41.35 | 83.8% | 1 | Nov 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 70 20 | n/a | n/a | 5 | Oct 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 30 34 | 1.09 | 3019.27% | 4 | May 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 6 1 | n/a | n/a | 3 | Feb 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 54 47 | n/a | n/a | 5 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 50 20 | 2.45 | 716.33% | 6 | Jul 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 216 120 | n/a | n/a | 1 | May 3, 2021 |